Utah Medical Products, Inc. (UTMD)

NMS – Real Time Price. Currency in USD

72.08

+0.14 (0.20%)

Market open: Aug 12, 2026, 1:24 PM EDT

71.94

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Stock details

Previous close: 72.5$
Day's range: 72 - 72.5$
52-week range: 53.66 - 75.75$
Volume: 847
Average volume: 20 904
Beta: 0.37
EPS (TTM): N/A
PE ratio (TTM): 22.08
Forward P/E: N/A
Market cap: 230 841 806
Shares outstanding: 3 184 025
Dividend yield: $1.72 (1.72%)
Next earnings date: N/A
Sector: Healthcare
Industry: Medical Instruments & Supplies

About the company

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable periton... read more

CEO: Kevin Cornwell
Country: United States
IPO Date
Employees: 152
Fiscal Year End: January - December
Website: https://www.utahmed.com

Revenue Breakdown

Gynecology/Electrosurgery/Urology / 51.19%

Neonatal / 20.79%

Blood Pressure Monitoring and Accessories / 17.63%

News

No Data

There are no news for this stock.

Chart: UTMD

Loading Chart...

Overall Score

4.6 / 1046%

Octagon View

Strength & Weakness

Cash reserves $0.0 barely cover the upcoming debt maturities $194.0K

Total current assets $100.6M exceed Total current liabilities $2.1M, highlighting excellent liquidity

Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management

The company has no interest-bearing debt, showcasing excellent financial strength

Financial Strength

NAME	RATIO	INDUSTRY	SCORE
Current ratio	48.62	3.39	10
Quick ratio	44.27	2.51	10
Debt to Equity	0.00	0.29	10
Debt to Assets	0.00	0.62	10
Interest coverage	N/A	24.85	10
Weighted average score			10

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)

Values in USD (B=Billions, M=Millions, K=Thousands)

METRIC	2022	2023	2024	2025	TTM
Total Revenue	52M	50M	41M	39M	36M
Gross Profit	26M	24M	22M	20M	19M
Operating Income	20M	18M	16M	13M	10M
Net Income	16M	17M	14M	11M	10M
EBITDA	28M	25M	19M	16M	13M

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAME	RATIO	INDUSTRY	SCORE
Gross margin %	55.60	41.34	10
Operating margin %	31.15	-2.18	10
Net margin %	31.49	-102.17	10
EBITDA margin %	33.80	-190.06	10
Cash flow margin %	N/A	-114.06	1.0
Weighted average score			8.2

Net Margin

Effectiveness

NAME	RATIO	INDUSTRY	SCORE
ROA	8.95	-24.67	8.0
ROE	9.25	-28.89	6.0
ROIC	9.24	-52.66	6.0
ROCE	2.17	24.39	5.0
Weighted average score			6.3

Estimated EPS vs Actual EPS

Forecast

NAME	REVENUE GROWTH	EPS GROWTH	SCORE
Current quarter	N/A	N/A	1.0
Next quarter	N/A	N/A	1.0
Current year	N/A	N/A	1.0
Next year	N/A	N/A	1.0
Weighted average score			1.0

Analyst Rating

Growth

NAME	REVENUE	NET INCOME	EPS	FCF	SCORE
Q/Q	-2.2	3.15	N/A	-11.54	1.8
Y/Y	-14.3	-11.87	N/A	-30.39	1.0
3y average	-9.42	-11.41	N/A	-9.33	1.0
5y average	-1.07	2.82	N/A	-4.47	1.8
Weighted average score					1.4

Revenue Growth Rate vs. Industry

Valuation

NAME	RATIO	INDUSTRY	SCORE
P/E	21.72	13.53	3.8
PEG (5yr expected)	N/A	4.25	1.0
P/S	6.30	31.48	6.4
P/B	1.86	3.36	7.2
Weighted average score			4.6

DCF Model

DCF Model Period5 years

Discount rate8%

Perpetual growth rate3%

Revenue 5 year CAGR-0.54%

FCF 5 year CAGR4

Fair value85.87$

Stock price72.58$

Dividend

NAME	CURRENT	INDUSTRY	SCORE
Dividend yield	2.02	2.02	7.0
Payout ratio	21.22	21.22	4.0
5-year dividend growth rate	1.63	1.63	3.0
Years of dividend increase	3.00	3.00	3.0
Weighted average score			4.3

Fair Value

$85.87

UndervaluedStock priceOvervalued

$72.58

Economic Moat

NAME	SCALE	SCORE
Market share	None	1.0
Intangible assets	None	1.0
Switching costs	None	1.0
Network effect	None	1.0
Economies of scale	None	1.0
Weighted average score		1.0

About the company

CEO

Kevin Cornwell

Country

United States

IPO Date

Employees

152

Fiscal Year End

January - December

Website

https://www.utahmed.com

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Current ratio

48.62

3.39

Quick ratio

44.27

2.51

Debt to Equity

0.00

0.29

Debt to Assets

0.00

0.62

Interest coverage

N/A

24.85

Weighted average score

METRIC

2022

2023

2024

2025

TTM

Total Revenue

52M

50M

41M

39M

36M

Gross Profit

26M

24M

22M

20M

19M

Operating Income

20M

18M

16M

13M

10M

Net Income

16M

17M

14M

11M

10M

EBITDA

28M

25M

19M

16M

13M

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Gross margin %

55.60

41.34

Operating margin %

31.15

-2.18

Net margin %

31.49

-102.17

EBITDA margin %

33.80

-190.06

Cash flow margin %

N/A

-114.06

1.0

Weighted average score

8.2

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

ROA

8.95

-24.67

8.0

ROE

9.25

-28.89

6.0

ROIC

9.24

-52.66

6.0

ROCE

2.17

24.39

5.0

Weighted average score

6.3

NAME

REVENUE GROWTH

EPS GROWTH

SCORE

Current quarter

N/A

1.0

Next quarter

N/A

1.0

Current year

N/A

1.0

Next year

N/A

1.0

Weighted average score

1.0

NAME

REVENUE

NET INCOME

EPS

FCF

SCORE

Q/Q

-2.2

3.15

N/A

-11.54

1.8

Y/Y

-14.3

-11.87

N/A

-30.39

1.0

3y average

-9.42

-11.41

N/A

-9.33

1.0

5y average

-1.07

2.82

N/A

-4.47

1.8

Weighted average score

1.4

NAME

RATIO

INDUSTRY

5Q TREND

SCORE

P/E

21.72

13.53

3.8

PEG (5yr expected)

N/A

4.25

1.0

P/S

6.30

31.48

6.4

P/B

1.86

3.36

7.2

Weighted average score

4.6

NAME

CURRENT

INDUSTRY

SCORE

Dividend yield

2.02

7.0

Payout ratio

21.22

4.0

5-year dividend growth rate

1.63

3.0

Years of dividend increase

3.00

3.0

Weighted average score

4.3

NAME

SCALE

SCORE

Market share

None

1.0

Intangible assets

None

1.0

Switching costs

None

1.0

Network effect

None

1.0

Economies of scale

None

1.0

Weighted average score

1.0

Search stocks

Utah Medical Products, Inc. (UTMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Utah Medical Products, Inc. (UTMD)

Stock details

About the company

Revenue Breakdown

News

Chart: UTMD

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$85.87

$72.58

Economic Moat

Stock details

About the company

Revenue Breakdown

News

Chart: UTMD

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$85.87

$72.58

Economic Moat